RARγ activation is important to prostate cancer cell proliferation because the use of a RARγ agonist or a low level of ATRA (0.1 to 1 nM) to activate just RARγ stimulated the growth of and colony formation by prostate cancer cell line cells [63]. Here, RARG is linked to prostate carcinoma.